Peak Pharmaceuticals, Inc. (OTCMKTS:PKPH – Get Free Report) shares fell 0.6% during mid-day trading on Monday . The stock traded as low as $0.7270 and last traded at $0.90. 253 shares changed hands during mid-day trading, a decline of 97% from the average session volume of 9,053 shares. The stock had previously closed at $0.9055.
Peak Pharmaceuticals Price Performance
The company has a 50 day simple moving average of $1.50 and a 200-day simple moving average of $1.76.
Peak Pharmaceuticals Company Profile
Peak Pharmaceuticals, Inc manufactures and markets pharmaceutical level products containing phytocannabinoids, an abundant and pharmaceutically active component of industrial hemp for the prevention and alleviation of various conditions and diseases. The company was founded on December 18, 2007 and is headquartered in Scottsdale, AZ.
See Also
- Five stocks we like better than Peak Pharmaceuticals
- D-Wave Earnings Looked Weak, But Investors May Be Missing This
- Nebius Upside Expands as AI Feedback Loop Intensifies
- Insider Trades: Okta and Abbott See Buys, Micron Insiders Sell
- Plug Power Flips The Switch On Profitability
Receive News & Ratings for Peak Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Peak Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
-online-lending--digital-banking-etf-logo-1200x675.png){kind=logo}